{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:07:52Z","timestamp":1788282472409,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.path.2022.09.011","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:12:24Z","timestamp":1675354344000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Back to Biochemistry"],"prefix":"10.1016","volume":"16","author":[{"given":"Sounak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2022.09.011_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2022.09.011_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","article-title":"Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia","volume":"44","author":"Gill","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.path.2022.09.011_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fped.2017.00155","article-title":"Review of Pediatric Pheochromocytoma and Paraganglioma","volume":"5","author":"Bholah","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.path.2022.09.011_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2022.09.011_bib5","doi-asserted-by":"crossref","first-page":"e28981","DOI":"10.1002\/pbc.28981","article-title":"Pseudohypoxic pheochromocytomas and paragangliomas dominate in children","volume":"68","author":"Redlich","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.path.2022.09.011_bib6","doi-asserted-by":"crossref","first-page":"bvaa039","DOI":"10.1210\/jendso\/bvaa039","article-title":"Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)","volume":"4","author":"de Tersant","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.path.2022.09.011_bib7","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","article-title":"Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations","volume":"29","author":"King","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2022.09.011_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1737","article-title":"Mitochondrial tumour suppressors: a genetic and biochemical update","volume":"5","author":"Gottlieb","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.path.2022.09.011_bib9","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/sj.onc.1209594","article-title":"Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer","volume":"25","author":"King","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.path.2022.09.011_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2022.09.011_bib11","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.path.2022.09.011_bib12","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.celrep.2020.03.022","article-title":"TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2alpha-Driven Mesenchymal Transition","volume":"30","author":"Morin","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.path.2022.09.011_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/ERC-14-0254","article-title":"Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad","volume":"21","author":"Haller","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.path.2022.09.011_bib15","doi-asserted-by":"crossref","first-page":"268ra177","DOI":"10.1126\/scitranslmed.3009961","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"6","author":"Killian","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.path.2022.09.011_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAI.0000000000000920","article-title":"SDHC Methylation Pattern in Patients With Carney Triad","volume":"29","author":"Daumova","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.path.2022.09.011_bib17","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1210\/jc.2019-00175","article-title":"A\u00a0Full Phenotype of Paraganglioma Linked to a Germline SDHB Mosaic Mutation","volume":"104","author":"Cardot-Bauters","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0b013e3181d6150d","article-title":"Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types","volume":"34","author":"Gill","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib19","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/PAS.0b013e3182260752","article-title":"Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.09.011_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41379-021-00998-1","article-title":"Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients","volume":"35","author":"Fuchs","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib21","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1097\/PAS.0b013e3180caa0b5","article-title":"Pulmonary chondroma: a tumor associated with Carney triad and different from pulmonary hamartoma","volume":"31","author":"Rodriguez","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/his.13945","article-title":"Loss of succinate dehydrogenase B immunohistochemical expression distinguishes pulmonary chondromas from hamartomas","volume":"75","author":"Chatzopoulos","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2022.09.011_bib23","doi-asserted-by":"crossref","first-page":"T91","DOI":"10.1530\/ERC-15-0268","article-title":"15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5","volume":"22","author":"Benn","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.path.2022.09.011_bib24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.5858\/arpa.2017-0285-RS","article-title":"Succinate Dehydrogenase Complex: An Updated Review","volume":"142","author":"Rasheed","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2022.09.011_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1095-144","article-title":"Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency","volume":"11","author":"Bourgeron","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2022.09.011_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PAS.0b013e3182671155","article-title":"Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors","volume":"37","author":"Dwight","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib27","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.path.2022.09.011_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib29","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.path.2022.09.011_bib30","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas","volume":"92","author":"Timmers","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/humu.21269","article-title":"Are we overestimating the penetrance of mutations in SDHB?","volume":"31","author":"Schiavi","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.path.2022.09.011_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbabio.2012.12.005","article-title":"Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors","volume":"1827","author":"Baysal","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.path.2022.09.011_bib34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1210\/jc.2008-0569","article-title":"Maternal transmission of symptomatic disease with SDHD mutation: fact or fiction?","volume":"93","author":"Neumann","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gde.2011.12.001","article-title":"Genomic imprinting: recognition and marking of imprinted loci","volume":"22","author":"Abramowitz","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.path.2022.09.011_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","article-title":"SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma","volume":"17","author":"Kunst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2022.09.011_bib37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.path.2022.09.011_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":"Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD","volume":"31","author":"Ricketts","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.path.2022.09.011_bib39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","article-title":"Bayesian approach to determining penetrance of pathogenic SDH variants","volume":"55","author":"Benn","year":"2018","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.path.2022.09.011_bib40","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/js.2018-00120","article-title":"Pathogenicity and Penetrance of Germline SDHA Variants in Pheochromocytoma and Paraganglioma (PPGL)","volume":"2","author":"Maniam","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.path.2022.09.011_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","article-title":"Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study","volume":"33","author":"Favier","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2022.02.009","article-title":"Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions","volume":"123","author":"Chatzopoulos","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12022-016-9439-2","article-title":"Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome","volume":"27","author":"Gupta","year":"2016","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib45","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.21037\/atm.2019.09.143","article-title":"Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma","volume":"7","author":"Trpkov","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.path.2022.09.011_bib46","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12022-018-9534-7","article-title":"Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma","volume":"29","author":"Cheung","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib49","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/modpathol.2012.153","article-title":"Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors","volume":"26","author":"Wagner","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-018-2791-4","article-title":"Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma","volume":"372","author":"Taieb","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.path.2022.09.011_bib52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/cen.14106","article-title":"Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis","volume":"91","author":"Satapathy","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.path.2022.09.011_bib53","article-title":"The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations","volume":"7","author":"Asa","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.path.2022.09.011_bib54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lio2.122","article-title":"Head and neck paragangliomas: A two-decade institutional experience and algorithm for management","volume":"2","author":"Smith","year":"2017","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.path.2022.09.011_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.path.2022.09.011_bib56","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1210\/jcem.86.11.8034","article-title":"Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients","volume":"86","author":"Erickson","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib57","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib58","first-page":"5153","article-title":"Dopamine excess in patients with head and neck paragangliomas","volume":"30","author":"Van Der Horst-Schrivers","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.path.2022.09.011_bib59","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1056\/NEJM199512213332504","article-title":"Images in clinical medicine. Paraganglioma of the middle ear","volume":"333","author":"Applebaum","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2022.09.011_bib60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archotol.124.10.1133","article-title":"Vagal paraganglioma: a review of 46 patients treated during a 20-year period","volume":"124","author":"Netterville","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"Suppl 1","key":"10.1016\/j.path.2022.09.011_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6061\/clinics\/2012(Sup01)05","article-title":"Head and neck paragangliomas: clinical and molecular genetic classification","volume":"67","author":"Offergeld","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.path.2022.09.011_bib62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00439-003-0969-6","article-title":"Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect","volume":"113","author":"Astrom","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.path.2022.09.011_bib63","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1158\/1078-0432.CCR-10-0637","article-title":"Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma","volume":"16","author":"Cerecer-Gil","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2022.09.011_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214728","article-title":"Carotid body tumour associated with cyanotic heart disease","volume":"2016","author":"Mak","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.path.2022.09.011_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/PAI.0000000000000715","article-title":"Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56","volume":"28","author":"Kriegsmann","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.path.2022.09.011_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-020-09618-1","article-title":"The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma","volume":"31","author":"Kimura","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12022-020-09632-3","article-title":"Images in Endocrine Pathology: Progressive Loss of Sustentacular Cells in a Case of Recurrent Jugulotympanic Paraganglioma over a Span of 5 years","volume":"31","author":"Zhou","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib68","first-page":"1767","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck","volume":"44","author":"Duet","year":"2003","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.path.2022.09.011_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12022-009-9098-7","article-title":"Familial cervical paragangliomas with lymph node metastasis expressing somatostatin receptor type 2A","volume":"21","author":"Kimura","year":"2010","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/dc.24338","article-title":"Application of GATA 3 and TTF-1 in differentiating parathyroid and thyroid nodules on cytology specimens","volume":"48","author":"Shi","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.path.2022.09.011_bib71","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12022-020-09615-4","article-title":"Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors","volume":"31","author":"Turchini","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.humpath.2019.08.013","article-title":"Frequency and extent of cytokeratin expression in paraganglioma: an immunohistochemical study of 60 cases from 5 anatomic sites and review of the literature","volume":"93","author":"Dermawan","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12022-018-9532-9","article-title":"Immunohistochemical Biomarkers in Thyroid Pathology","volume":"29","author":"Baloch","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12105-017-0803-4","article-title":"Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000000283","article-title":"The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas","volume":"260","author":"Ellis","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.path.2022.09.011_bib76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamaoto.2019.1110","article-title":"Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades","volume":"145","author":"McCrary","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.path.2022.09.011_bib77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4158\/EP15725.OR","article-title":"Characteristics and Outcomes of Metastatic Sdhb and Sporadic Pheochromocytoma\/Paraganglioma: An National Institutes of Health Study","volume":"22","author":"Turkova","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.path.2022.09.011_bib78","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study","volume":"106","author":"Ebbehoj","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","article-title":"Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors","volume":"161","author":"Babic","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.path.2022.09.011_bib80","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib81","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejim.2009.08.002","article-title":"ACTH-producing pheochromocytoma: clinical considerations and concise review of the literature","volume":"20","author":"Nijhoff","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.path.2022.09.011_bib82","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-2006-924154","article-title":"Cushing's syndrome due to ectopic CRH secretion by adrenal pheochromocytoma accompanied by renal infarction","volume":"114","author":"Bayraktar","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.path.2022.09.011_bib83","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/pgmj.51.596.416","article-title":"Watery diarrhoea and hypokalaemia associated with a phaeochromocytoma","volume":"51","author":"Loehry","year":"1975","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.path.2022.09.011_bib84","first-page":"69","article-title":"Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.path.2022.09.011_bib85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12022-017-9489-0","article-title":"Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma\/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127)","volume":"28","author":"Gupta","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib86","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1093\/hmg\/ddaa201","article-title":"Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine","volume":"29","author":"Casey","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.path.2022.09.011_bib87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.path.2022.09.011_bib88","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00441-018-2801-6","article-title":"Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma","volume":"372","author":"Kluckova","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.path.2022.09.011_bib89","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A\u00a0HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"Plos Genet"},{"key":"10.1016\/j.path.2022.09.011_bib90","first-page":"105","article-title":"Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma","author":"Jiang","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12022-020-09655-w","article-title":"Dopamine beta-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma","volume":"32","author":"Kimura","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib92","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene","volume":"93","author":"Timmers","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2022.09.011_bib93","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2022.09.011_bib94","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-019-02553-5","article-title":"COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas\/paragangliomas","volume":"474","author":"Pierre","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2022.09.011_bib95","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.path.2022.09.011_bib96","doi-asserted-by":"crossref","first-page":"e0187398","DOI":"10.1371\/journal.pone.0187398","article-title":"Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma","volume":"12","author":"Koh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.path.2022.09.011_bib97","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:44:27Z","timestamp":1761749067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918122000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1875918122000848"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2022.09.011","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Back to Biochemistry","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2022.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}